Kirk Fry
39Patents
15h-index
33Co-inventors
81Inventor score
Filing activity: Jun 28, 1989 → Dec 1, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6905827B2 | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases | Emerging Cross-Sectional Technologies | 156 | Expired |
| US6114149A | Amplification of mixed sequence nucleic acid fragments | Chemistry; Metallurgy | 139 | Expired |
| US7026121B1 | Methods and compositions for diagnosing and monitoring transplant rejection | Chemistry; Metallurgy | 94 | Expired |
| US7235358B2 | Methods and compositions for diagnosing and monitoring transplant rejection | Physics | 69 | Expired |
| US5578444A | Sequence-directed DNA-binding molecules compositions and methods | Electricity | 54 | Expired |
| US5716780A | Method of constructing sequence-specific DNA-binding molecules | Chemistry; Metallurgy | 40 | Expired |
| US5693463A | Method of ordering sequence binding preferences of a DNA-binding molecule | Chemistry; Metallurgy | 37 | Expired |
| US5218099A | Post-transfusion, non-A, non-B hepatitis virus polynucleotides | Chemistry; Metallurgy | 37 | Expired |
| US5744131A | Sequence-directed DNA-binding molecules compositions and methods | Chemistry; Metallurgy | 30 | Expired |
| US7691569B2 | Methods and compositions for diagnosing and monitoring transplant rejection | Physics | 26 | Expired |
| US5738990A | Sequence-directed DNA-binding molecules compositions and methods | Chemistry; Metallurgy | 26 | Expired |
| US5869241A | Method of determining DNA sequence preference of a DNA-binding molecule | Electricity | 25 | Expired |
| US5766840A | Hepatitis G virus and molecular cloning thereof | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5128460A | Recombinant trichosanthin and coding sequence | Chemistry; Metallurgy | 17 | Expired |
| US6010849A | Sequence-directed DNA binding molecules compositions and methods | Electricity | 16 | Expired |
| US7785797B2 | Methods and compositions for diagnosing and monitoring transplant rejection | Physics | 15 | Active |
| US7879556B2 | Methods and compositions for diagnosing and monitoring transplant rejection | Emerging Cross-Sectional Technologies | 12 | Active |
| US5824507A | Hepatitis G virus and molecular cloning thereof | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8110364B2 | Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases | Emerging Cross-Sectional Technologies | 8 | Active |
| US7771950B2 | Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases | Emerging Cross-Sectional Technologies | 8 | Active |
| US7579148B2 | Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5874563A | Hepatitis G virus and molecular cloning thereof | Chemistry; Metallurgy | 7 | Expired |
| US5849532A | Hepatitis G virus and molecular cloning thereof | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5789559A | DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5856134A | Hepatitis G virus and molecular cloning thereof | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.